Literature DB >> 7077619

Bone demineralisation in patients with Turner's syndrome.

M A Smith, J Wilson, W H Price.   

Abstract

The hypothesis that the demineralisation associated with gonadal dysgenesis is analogous to post-menopausal osteoporosis was investigated. Bone mineral content of the distal forearm was measured in 11 adult patients with Turner's syndrome aged 18 to 57 years. As a group these patients were significantly demineralised (p less than 0.001) when compared with normal subjects. A bimodal distribution of bone mineral was demonstrated, the eight patients below the normal range having a bone mineral content 73% of normal. This may be the usual bone mineral content for a large proportion of Turner's patients. No steady reduction in mineralisation with age was demonstrated. The number of osteoporotic type fractures was obtained from the records of 36 adult patients with Turner's syndrome. From the cumulative total years at risk (770 patient years) from the age of 15 years, it was found that the number of fractures of the distal radius corresponded to the normal premenopausal rather than post-menopausal fracture incidence. The absence of any reduction in bone mineral content with age and no clear evidence of an increase in frequency of fractures both suggest that the demineralisation associated with Turner's syndrome is not analogous to post-menopausal osteoporosis. The regular use of long term oestrogen therapy as a treatment for 'osteoporosis' in these patients is therefore not justified.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7077619      PMCID: PMC1048837          DOI: 10.1136/jmg.19.2.100

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  Changing patterns in endometrial adenocarcinoma: a study of 291 consecutive cases at a large private hospital, 1960-1973.

Authors:  B C Quint
Journal:  Am J Obstet Gynecol       Date:  1975-06-15       Impact factor: 8.661

2.  Proceedings: Bone mineral content in patients with gonadal dysfunction.

Authors:  W D Risch; D H Banzer; L Moltz; U Schneider; R Rudloff
Journal:  AJR Am J Roentgenol       Date:  1976-06       Impact factor: 3.959

3.  Increased risk of endometrial carcinoma among users of conjugated estrogens.

Authors:  H K Ziel; W D Finkle
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

4.  [Endocrine disorders and Scheuermann's disease].

Authors:  G Müller; N Gschwend
Journal:  Arch Orthop Unfallchir       Date:  1969

5.  Roentgenographic abnormalities in phenotypic females with gonadal dysgenesis. A comparison of chromatin positive patients and chromatin negative patients.

Authors:  L Preger; H L Steinbach; P Moskowitz; A L Scully; M B Goldberg
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-12

6.  Bone measurement in the differential diagnosis of osteopenia and osteoporosis.

Authors:  S M Garn; A K Poznanski; J M Nagy
Journal:  Radiology       Date:  1971-09       Impact factor: 11.105

7.  Osteoporosis in ovarian dysgenesis.

Authors:  D M Brown; J Jowsey; D S Bradford
Journal:  J Pediatr       Date:  1974-06       Impact factor: 4.406

8.  Orthopedic aspects of the XO (Turner's) syndrome.

Authors:  R K Beals
Journal:  Clin Orthop Relat Res       Date:  1973 Nov-Dec       Impact factor: 4.176

9.  Association of exogenous estrogen and endometrial carcinoma.

Authors:  D C Smith; R Prentice; D J Thompson; W L Herrmann
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

10.  Effect of sex hormones on bone in primary osteoporosis.

Authors:  B L Riggs; J Jowsey; P J Kelly; J D Jones; F T Maher
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  9 in total

Review 1.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

2.  Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.

Authors:  R W Naeraa; K Brixen; R M Hansen; C Hasling; L Mosekilde; J H Andresen; P Charles; J Nielsen
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

3.  Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome.

Authors:  C R Holroyd; J H Davies; P Taylor; K Jameson; C Rivett; C Cooper; E M Dennison
Journal:  Osteoporos Int       Date:  2010-02-05       Impact factor: 4.507

4.  Estrogen replacement therapy for postmenopausal osteoporosis.

Authors:  J G Roberts; C E Webber; C A Woolever
Journal:  Can Fam Physician       Date:  1986-04       Impact factor: 3.275

5.  Prenatal diagnosis of the Turner syndrome: what to tell the parents.

Authors:  J M Connor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

6.  Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy.

Authors:  P Pitukcheewanont; N Numbenjapon; D Safani; S Rossmiller; V Gilsanz; G Costin
Journal:  Osteoporos Int       Date:  2010-09-09       Impact factor: 4.507

7.  Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients.

Authors:  R W Holl; D Kunze; H Etzrodt; W Teller; E Heinze
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

Review 8.  Fracture risk and bone mineral density in Turner syndrome.

Authors:  Vladimir K Bakalov; Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2008-04-15       Impact factor: 6.514

Review 9.  Hormones and bone health in postmenopausal women.

Authors:  Robert Lindsay
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.